Department of Cell Morphology and Molecular Neurobiology, Ruhr-University Bochum, Universitätsstr. 150, 44801 Bochum, Germany.
Cells. 2022 May 28;11(11):1773. doi: 10.3390/cells11111773.
Oligodendrocytes are the myelinating cells of the central nervous system. The physiological importance of oligodendrocytes is highlighted by diseases such as multiple sclerosis, in which the myelin sheaths are degraded and the axonal signal transmission is compromised. In a healthy brain, spontaneous remyelination is rare, and newly formed myelin sheaths are thinner and shorter than the former ones. The myelination process requires the migration, proliferation, and differentiation of oligodendrocyte precursor cells (OPCs) and is influenced by proteins of the extracellular matrix (ECM), which consists of a network of glycoproteins and proteoglycans. In particular, the glycoprotein tenascin-C (Tnc) has an inhibitory effect on the differentiation of OPCs and the remyelination efficiency of oligodendrocytes. The structurally similar tenascin-R (Tnr) exerts an inhibitory influence on the formation of myelin membranes in vitro. When Tnc knockout oligodendrocytes were applied to an in vitro myelination assay using artificial fibers, a higher number of sheaths per single cell were obtained compared to the wild-type control. This effect was enhanced by adding brain-derived neurotrophic factor (BDNF) to the culture system. oligodendrocytes behaved differently in that the number of formed sheaths per single cell was decreased, indicating that Tnr supports the differentiation of OPCs. In order to study the functions of tenascin proteins in vivo and mice were exposed to Cuprizone-induced demyelination for a period of 10 weeks. Both and mouse knockout lines displayed a significant increase in the regenerating myelin sheath thickness after Cuprizone treatment. Furthermore, in the absence of either tenascin, the number of OPCs was increased. These results suggest that the fine-tuning of myelin regeneration is regulated by the major tenascin proteins of the CNS.
少突胶质细胞是中枢神经系统的髓鞘形成细胞。少突胶质细胞的生理重要性在多发性硬化症等疾病中得到了突出体现,在这些疾病中,髓鞘被降解,轴突信号传递受损。在健康的大脑中,自发的髓鞘再生很少见,新形成的髓鞘比以前的更薄更短。髓鞘形成过程需要少突胶质前体细胞(OPC)的迁移、增殖和分化,并受细胞外基质(ECM)蛋白的影响,ECM 由糖蛋白和蛋白聚糖组成的网络构成。特别是糖蛋白 tenascin-C(Tnc)对 OPC 的分化和少突胶质细胞的髓鞘再生效率具有抑制作用。结构上相似的 tenascin-R(Tnr)对体外髓鞘膜的形成具有抑制作用。当 Tnc 敲除少突胶质细胞应用于使用人工纤维的体外髓鞘形成测定时,与野生型对照相比,每个细胞获得的鞘数量更高。向培养系统中添加脑源性神经营养因子(BDNF)可增强该效果。然而,tnr 敲除的少突胶质细胞的行为则不同,每个细胞形成的鞘数量减少,表明 Tnr 支持 OPC 的分化。为了研究 tenascin 蛋白在体内的功能,将 和 小鼠暴露于 Cuprizone 诱导的脱髓鞘 10 周。在 Cuprizone 处理后, 和 小鼠敲除系均显示再生髓鞘厚度显著增加。此外,在没有任何一种 tenascin 的情况下,OPC 的数量增加。这些结果表明,中枢神经系统主要的 tenascin 蛋白调节髓鞘再生的精细调控。